ATTENTION DEFICIT HYPERACTIVITY DISORDER PDF

This retrospective database analysis used data from the Healthcare Cost and Utilization Project’s Nationwide Inpatient Sample (NIS) to examine common primary diagnoses among children and adolescents hospitalized with a secondary diagnosis of attention- deficit/hyperactivity disorder (ADHD) and asses[r]

Attention deficit/hyperactivity disorder (ADHD) often presents as an impairing lifelong condition in adults; yet it is currently underdiagnosed and undertreated in many European countries. This analysis examines the characteristics of adult patients with ADHD in a European (EUR) and non-European (NE[r]

analysis of Canadian open-label studies
Ruth A Dickson 1* , Ellen Maki 2 , Christopher Gibbins 3 , Stephen W Gutkin 4 , Atilla Turgay 5 and Margaret D Weiss 3
Abstract
Background: The relatively short durations of the initial pivotal randomized placebo-controlled trials involving atomoxetine H[r]

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral psychiatric disorder that afflicts children, with a reported prevalence of 2.4% to 19.8% worldwide. Stimulants (methylphenidate [MPH] and amphetamine) are considered first-line ADHD pharmacotherapy.

Attention deficit hyperactivity disorder is the most common childhood neurobehavioral disorder with well documented adverse consequences in adolescence and adulthood, yet 60-80% of cases go undiagnosed. Routine screening is not practiced in most pediatric outpatient services and little information e[r]

Chris J Bushe * and Nicola C Savill
Abstract
Background: Attention Deficit Hyperactivity Disorder (ADHD) is becoming an increasingly commonly diagnosed and treated childhood illness. Untreated ADHD is recognised as an independent risk factor for suicide-related events[r]

Attention deficit/hyperactivity disorder (ADHD) is a common disorder that often presents in childhood and is associated with increased healthcare resource use. The aims of this study were to characterise the epidemiology of diagnosed ADHD in the UK and determine the resource use and financial costs[r]

A wide range of evidence supports the methylphenidate (MPH)-induced enhancement of prefrontal cortex (PFC) functioning and improvements in behavioral symptoms in patients with attention deficit hyperactivity disorder (ADHD). Although working memory (WM) has been hypothesized to be impaired in patien[r]

Efficacy and safety profiles by sex and age (6-9 vs 10-12 years) and magnitude and duration of effect by effect size overall and across the day of lisdexamfetamine dimesylate (LDX) vs placebo were assessed.

Chế độ ăn lành mạnh có thể giúp trẻ giảm triệu chứng “tăng động” Duy trì chế độ ăn lành mạnh có thể giúp ích cho trẻ tăng động giảm tập trung trong quá trình điều trị. Một nghiên cứu mới đây cho thấy duy trì chế độ ăn lành mạnh có thể giúp ích cho trẻ tăng động giảm tập trung (attention

Xem Thêm " AUTOIMMUNE DISORDER "

Xem Thêm " ENVIRONMENTAL RISK FACTORS AND GENE ENVIRONMENT INTERACTION IN ATTENTION DEFICIT HYPERACTIVITY DISORDER "